D-0235-2022 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- November 24, 2021
- Initiation Date
- October 28, 2021
- Termination Date
- February 27, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 64,978 patches
Product Description
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide and Puerto Rico
Code Information
Lot# 1369117B, exp. date 11/2021